Cardiac implantable electronic devices and systemic cancer therapies were reviewed historically, but no primary quantitative clinical trial data or specific effect sizes were reported in the provided text.
Advances in cardiac implantable electronic devices over the past 65 years have revolutionized the management of bradycardia, tachyarrhythmias, and heart failure.
Takashi Kurita (Thu,) conducted a review in Cardiac arrhythmias and cancer. Cardiac implantable electronic devices (CIED) and systemic cancer therapies was evaluated. Cardiac implantable electronic devices and systemic cancer therapies were reviewed historically, but no primary quantitative clinical trial data or specific effect sizes were reported in the provided text.